Fundraising GuideGrowth

How to Raise a Growth Round for Life Sciences Startups

A complete, tactical playbook — investor expectations, benchmark metrics, a month-by-month fundraising timeline, and a curated list of active VCs writing checks at the Growth stage in Life Sciences.

$50M+
Typical check size
10-20%
Equity dilution
4–8 months to close from mandate or banker engagement
Time to close

What Growth Investors Expect

Later stage growth capital. For Life Sciences startups, investors at the Growth stage evaluate a specific set of signals before writing a check.

Clear path to $100M+ ARR or equivalent revenue scale
Demonstrated operational efficiency with improving margins
Credible IPO readiness or strategic exit thesis within 3–5 years
Proven management team with public company experience (optional but valued)
Market leadership position in a large and growing category

Typical Investors

  • Late-stage growth equity (General Atlantic, KKR Growth, Insight Partners)
  • Crossover hedge funds
  • Sovereign wealth funds
  • Pre-IPO specialist funds
  • Strategic acquirers evaluating minority investment

Pitch Deck Focus Areas

  • Market leadership proof points
  • Revenue quality and predictability
  • Profitability roadmap
  • Capital structure and secondary considerations
  • Long-term strategic vision and exit scenarios

Key Metrics Life Sciences Investors Scrutinize

Every sector uses different proxies to evaluate startup health. In Life Sciences, investors have well-defined benchmarks refined over hundreds of deals. Know these before walking into any partner meeting.

Metrics Investors Track

  • Clinical milestone progress (IND, Phase I/II/III)
  • Indication breadth and pipeline depth
  • IP portfolio and patent filings
  • Key opinion leader (KOL) endorsements
  • Regulatory pathway clarity

Growth Stage Benchmarks

  • IND filing before seed close
  • At least one Phase I data read-out for Series A
  • 3+ year runway preferred
  • Experienced scientific advisory board
  • Orphan drug designation (if applicable)

Active Life Sciences VCs — Growth Stage

View all

Browse our full database of Life Sciences investors.

Search Life Sciences VCs

Life Sciences Accelerator Programs

Accelerators are an alternative or complement to direct VC fundraising — especially at pre-seed and seed stage. Top programs offer $50M+–$50M+ plus mentorship, network access, and Demo Day investor exposure.

Notable accelerators with Life Sciences focus include Y Combinator, Techstars, and sector-specific programs. Use our accelerator search to filter by industry, location, and stage.

Browse all Life Sciences accelerators

Month-by-Month Fundraising Timeline

A realistic action plan for running a disciplined Growth fundraising process in Life Sciences. Time-box each phase and track investor pipeline weekly.

1

Month 1

  • Engage growth-stage bankers and advisors
  • Prepare CIM (confidential information memorandum)
  • Identify strategic vs. financial investor mix
2

Month 2

  • Targeted outreach to growth equity and crossover funds
  • Formal management presentations to 6–10 funds
  • Provide data room access on NDA basis
3

Month 3

  • Deep operational and financial diligence
  • Receive term sheets from 2–4 parties
  • Evaluate primary vs. secondary components
4

Month 4

  • Negotiate valuation, governance, and liquidity provisions
  • Manage secondary tender for early shareholders
  • Sign definitive documents
5

Month 5–6

  • Regulatory filings if required (Hart-Scott-Rodino)
  • Close and distribute proceeds
  • Plan for IPO readiness or next milestone

Common Growth Fundraising Mistakes

These are the most frequent errors that derail Growth rounds for Life Sciences founders — often after months of effort.

1

Optimizing for valuation over finding the right capital partner

2

Ignoring the secondary liquidity needs of early employees and angels

3

Not preparing for the rigorous financial audit that growth-stage investors require

4

Mixing growth capital with operational inefficiency — investors will notice

5

Failing to show a credible path to profitability or cash flow break-even

Fundraising Templates for Life Sciences Startups

Use these free, stage-specific templates tailored to Life Sciences investors. Each is designed to address the metrics, structure, and narratives that Growth VCs expect to see.

Life Sciences Growth Pitch Deck

Slide-by-slide template with industry-specific metrics and narrative structure.

View template

Life Sciences Growth Business Plan

Full business plan template with financial model and operational roadmap.

View template

Life Sciences Market Analysis

TAM/SAM/SOM framework and competitive landscape template for Life Sciences.

View template

Valuation Calculator

Estimate your Growth valuation range using comparable Life Sciences deals and revenue multiples.

Open calculator

Frequently Asked Questions

How much should I raise in a Growth round for a Life Sciences startup?

Life Sciences startups at the Growth stage typically raise $50M+. The right amount depends on your burn rate, team size, and the specific milestones you need to hit before your next raise. A common rule of thumb is to raise 18–24 months of runway. Raising too little risks running out of capital mid-traction; raising too much can dilute founders and set unrealistic valuation expectations for the next round.

What equity percentage will I give up in a Growth round?

In the Growth stage, investors typically target 10-20% ownership. The exact dilution depends on your valuation, which in Life Sciences is driven by team pedigree, market size, and early traction signals. Use a dilution calculator to model scenarios before entering negotiations and understand how the Growth dilution compounds with future rounds.

What are the most important metrics for raising a Growth round in Life Sciences?

Life Sciences investors at the Growth stage focus heavily on the leading indicators that predict long-term success. The metrics section above outlines the most critical ones. At the Growth stage, the key is demonstrating that you understand the right metrics for your business — even if you haven't yet hit all benchmarks — and that you have a credible plan to reach them with the capital raised.

How long does it take to close a Growth round in Life Sciences?

Based on typical market cycles, Growth fundraising processes for Life Sciences companies take 4–8 months to close from mandate or banker engagement. This includes preparation time (1–4 weeks), running the process (4–10 weeks), and legal close (2–6 weeks). Having your data room, cap table, and metrics deck ready before the first meeting can materially shorten the timeline.

Which types of investors are most active in Life Sciences at the Growth stage?

The most active capital sources for Life Sciences startups at the Growth stage include: Late-stage growth equity (General Atlantic, KKR Growth, Insight Partners), Crossover hedge funds, Sovereign wealth funds, Pre-IPO specialist funds, Strategic acquirers evaluating minority investment. Specialized Life Sciences funds that understand sector-specific metrics are often more efficient partners than generalist investors — they do less primary diligence and can add more sector-relevant value post-investment.